GB0021421D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB0021421D0
GB0021421D0 GBGB0021421.3A GB0021421A GB0021421D0 GB 0021421 D0 GB0021421 D0 GB 0021421D0 GB 0021421 A GB0021421 A GB 0021421A GB 0021421 D0 GB0021421 D0 GB 0021421D0
Authority
GB
United Kingdom
Prior art keywords
sub
hydrogen
specific substituents
compounds
independently
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0021421.3A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford Glycosciences UK Ltd
Original Assignee
Oxford Glycosciences UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford Glycosciences UK Ltd filed Critical Oxford Glycosciences UK Ltd
Priority to GBGB0021421.3A priority Critical patent/GB0021421D0/en
Publication of GB0021421D0 publication Critical patent/GB0021421D0/en
Priority to JP2002522888A priority patent/JP2004507501A/ja
Priority to ES01963157T priority patent/ES2282283T3/es
Priority to EP01963157A priority patent/EP1313471B1/en
Priority to PCT/GB2001/003862 priority patent/WO2002017915A1/en
Priority to AU2001284190A priority patent/AU2001284190A1/en
Priority to AT01963157T priority patent/ATE359073T1/de
Priority to DE60127845T priority patent/DE60127845T2/de
Priority to US10/371,964 priority patent/US7105554B2/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GBGB0021421.3A 2000-08-31 2000-08-31 Compounds Ceased GB0021421D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GBGB0021421.3A GB0021421D0 (en) 2000-08-31 2000-08-31 Compounds
JP2002522888A JP2004507501A (ja) 2000-08-31 2001-08-30 ベンジリデンチアゾリジンジオンおよび抗真菌剤としてのそれらの使用
ES01963157T ES2282283T3 (es) 2000-08-31 2001-08-30 Derivados de bencilideno tiazolidinadionas y su uso como agentes antifungicos.
EP01963157A EP1313471B1 (en) 2000-08-31 2001-08-30 Benzylidene thiazolidinediones and their use as antimycotic agents
PCT/GB2001/003862 WO2002017915A1 (en) 2000-08-31 2001-08-30 Benzylidene thiazolidinediones and their use as antimycotic agents
AU2001284190A AU2001284190A1 (en) 2000-08-31 2001-08-30 Benzylidene thiazolidinediones and their use as antimycotic agents
AT01963157T ATE359073T1 (de) 2000-08-31 2001-08-30 Benzylidenthiazolidindione und ihre verwendung als antimykotische mittel
DE60127845T DE60127845T2 (de) 2000-08-31 2001-08-30 Benzylidenthiazolidindione und ihre verwendung als antimykotische mittel
US10/371,964 US7105554B2 (en) 2000-08-31 2003-02-21 Benzylidene thiazolidinediones and their use as antimycotic agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0021421.3A GB0021421D0 (en) 2000-08-31 2000-08-31 Compounds

Publications (1)

Publication Number Publication Date
GB0021421D0 true GB0021421D0 (en) 2000-10-18

Family

ID=9898616

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0021421.3A Ceased GB0021421D0 (en) 2000-08-31 2000-08-31 Compounds

Country Status (9)

Country Link
US (1) US7105554B2 (ja)
EP (1) EP1313471B1 (ja)
JP (1) JP2004507501A (ja)
AT (1) ATE359073T1 (ja)
AU (1) AU2001284190A1 (ja)
DE (1) DE60127845T2 (ja)
ES (1) ES2282283T3 (ja)
GB (1) GB0021421D0 (ja)
WO (1) WO2002017915A1 (ja)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003205907A1 (en) * 2002-02-23 2003-09-09 Oxford Glycosciences (Uk) Ltd Thiazolidine antifungal agents
GB0204252D0 (en) * 2002-02-23 2002-04-10 Oxford Glycosciences Uk Ltd Novel compounds
EP1730103B1 (en) 2004-03-23 2010-05-26 Pfizer Limited Formamide derivatives useful as adrenoceptor
JP5284789B2 (ja) * 2005-11-15 2013-09-11 グライコフィ， インコーポレイテッド Ｏ−グリコシル化を減少している糖タンパク質の生成
US7731106B2 (en) * 2006-01-04 2010-06-08 Nano Mist International, Llc Air driven delivery system for sprayable media
US8637435B2 (en) * 2007-11-16 2014-01-28 Merck Sharp & Dohme Corp. Eukaryotic cell display systems
CA2715212A1 (en) 2008-03-03 2009-09-11 Glycofi, Inc. Surface display of recombinant proteins in lower eukaryotes
EP2300446B1 (en) 2008-05-20 2011-12-07 Merck Sharp & Dohme Corp. Efficient production of heterologous proteins using mannosyl transferase inhibitors
US8067339B2 (en) 2008-07-09 2011-11-29 Merck Sharp & Dohme Corp. Surface display of whole antibodies in eukaryotes
US8507224B2 (en) 2008-08-12 2013-08-13 Glycofi, Inc. Vectors and yeast strains for protein production: Ca2+ ATPase overexpression
KR20140114278A (ko) 2011-02-25 2014-09-26 머크 샤프 앤드 돔 코포레이션 변형된 ｏ-글리코실화를 갖는 단백질의 생산을 위한 효모 균주
WO2013018735A1 (ja) * 2011-07-29 2013-02-07 大正製薬株式会社 アミジン化合物又はその塩
WO2014024897A1 (ja) * 2012-08-06 2014-02-13 Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 チアゾリジンジオンおよびピロリジンジオン誘導体、並びにそれらを有効成分としてなる殺菌剤
US9261497B2 (en) 2012-10-16 2016-02-16 New York University Method of treating cancer with modulators of SCFSkp2
CA2916594C (en) 2013-07-04 2020-03-10 Novartis Ag O-mannosyltransferase deficient filamentous fungal cells and methods of use thereof
CN108064266A (zh) 2014-07-21 2018-05-22 格利科斯芬兰公司 在丝状真菌中具有哺乳动物样n-聚糖的糖蛋白的制备
WO2017215552A1 (en) 2016-06-14 2017-12-21 The University Of Hong Kong Antimicrobial compounds and methods for use thereof
CA3025884C (en) * 2016-06-24 2023-03-07 Ohio University Glucose transport inhibitors and methods of using same
RU2662153C1 (ru) * 2017-04-20 2018-07-24 Общество С Ограниченной Ответственностью "Дермавитал Групп" Гибридные эфиры на основе производных тиазолидин-2,4-диона и азолов (1н-1,3-имидазола и 1н-1,3,4-триазола) и их применение
RU2690161C1 (ru) * 2018-06-28 2019-05-31 Общество С Ограниченной Ответственностью "Дермавитал Групп" 3,5-Замещенные производные тиазолидин-2,4-диона, обладающие противомикробной активностью
RU2703997C1 (ru) * 2018-12-13 2019-10-23 Общество с ограниченной ответственностью "Л-Био" Гибридные амиды на основе триазола и тиазолидина, обладающие антимикробной активностью
CN112521382A (zh) * 2020-12-14 2021-03-19 西南大学 芦荟大黄素噻唑烷二酮类化合物及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6156175A (ja) * 1984-08-24 1986-03-20 Yamanouchi Pharmaceut Co Ltd ロダニン誘導体およびその製造法
ZA936492B (en) * 1992-09-10 1995-03-02 Lilly Co Eli Compounds useful as hypoglycemic agents and for treating Alzheimer's disease.
DE4318550A1 (de) * 1993-06-04 1994-12-08 Boehringer Mannheim Gmbh Aryliden-4-oxo-2-thioxo-3- thiazolidincarbonsäuren, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
JPH08109175A (ja) * 1994-10-07 1996-04-30 Torii Yakuhin Kk チアゾリジン−２−オンエステル誘導体
JPH08109174A (ja) * 1994-10-07 1996-04-30 Torii Yakuhin Kk チアゾリジン−２−オン誘導体
AU6330799A (en) * 1998-09-30 2000-04-17 Roche Diagnostics Gmbh Rhodanine carboxylic acid derivatives for the treatment and prevention of metabolic bone disorders
AU6331099A (en) * 1998-09-30 2000-04-17 Roche Diagnostics Gmbh Thiazolidine derivatives for the treatment and prevention of metabolic bone disorders
US6506755B2 (en) * 2000-02-03 2003-01-14 Hoffmann-La Roche Inc. Thiazolidinecarboxyl acids

Also Published As

Publication number Publication date
ES2282283T3 (es) 2007-10-16
JP2004507501A (ja) 2004-03-11
EP1313471A1 (en) 2003-05-28
US7105554B2 (en) 2006-09-12
DE60127845T2 (de) 2007-12-20
DE60127845D1 (de) 2007-05-24
US20040006112A1 (en) 2004-01-08
ATE359073T1 (de) 2007-05-15
EP1313471B1 (en) 2007-04-11
WO2002017915A1 (en) 2002-03-07
AU2001284190A1 (en) 2002-03-13

Similar Documents

Publication Publication Date Title
GB0021421D0 (en) Compounds
IS4425A (is) Arylþíósambönd sem varnarefni gegn bakteríum og veirum
IL157773A0 (en) 2-amino-propanol derivatives
MY125359A (en) Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods.
EP0669324A4 (en) CHINAZOLIN DERIVATIVES.
MXPA05010652A (es) Pirazoles sustituidos.
TW200510405A (en) Bridged n-arylsulfonylpiperidines as gamma-secretase inhibitors
DE60214591D1 (en) Pyrazolpyrimidinfungizide
RS20050556A (en) Viral polymerase inhibitors
GEP20074198B (en) N-aryl-2-oxazolidinone-5-carboxamides and their derivates and their use as antibacterials
SE0004245D0 (sv) Novel compounds and their use
IS6309A (is) Kínasólínafleiður
HK1072770A1 (en) Bicyclic compound
WO2004048340A8 (en) Sinomenine and sinomenine compounds, synthesis and use
CA2341890A1 (en) Oxygen-containing heterocyclic compounds
DE69505470T2 (de) Pyrrolocarbazol
CA2309474A1 (en) New 4-arylpiperidine derivatives for the treatment of pruritus
SI1377574T1 (ja)
MXPA06000372A (es) Compuestos de silicio y su uso.
WO2005121109A3 (en) Novel antiviral macrocycle derivatives and metal complexes, incorporating bridged macrocycles
CA2206125A1 (en) N-substituted hydrazinophenylsulphonylureas, as herbicides and plant growth regulators
CY1107515T1 (el) Συνθεση ενδιαμεσων χρησιμων στην παρασκευη τρικυκλικων ενωσεων
TWI256383B (en) Anthraquinone compound
RS20050181A (en) Novel benzonaphthyridines
TH14957EX (th) สารประกอบชนิดใหม่

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)